Baillie Gifford acquired 430k CME Group shares worth $110M. That's 0.09% of their equity portfolio (121st largest holding). Baillie Gifford started to build up the position in CME Group in Q3 2024 and continued to invest until Q2 2025. Since then they sold 40.4k shares. The stake costed the investor $92.8M, netting the investor a gain of 19% so far.